Re Agreement

Advanced Medical Solutions Grp PLC
09 June 2004


For Immediate Release                                             9th June2004



         Advanced Medical Solutions Group plc ('AMS' or 'the Company')

           Announces new supply agreement for its woundcare products



Winsford, UK: Advanced Medical Solutions, (AIM: AMS), the global woundcare
technology company, today announces that it has entered into a supply agreement
with DKSH Healthcare a Swiss based company and a subsidiary of Diethelm Keller
Group ('Diethelm').  Diethelm has expanded from an Asian distribution company to
a globally diversified enterprise, building on its core competencies in brand
management and operating with 6 key divisions, one of which is a healthcare
division.



This agreement covers a full range of advanced woundcare products, namely
alginates, hydrocolloids, films and foams.  Sales of the products are expected
to commence in July this year and will cover the following territories:
Malaysia, Hong Kong, Vietnam and Pakistan. Additional territories are expected
to be added over time.



Commenting on this announcement, Dr Don Evans, Chief Executive of AMS, stated:



'I am delighted that we have established a distributor for these new markets for
our products in the Far East and we look forward to working with Diethelm to
build our business in this region.'



Mr. Guido Oelkers, Executive Vice President and Global Head of Healthcare for
DKSH added:



'We are pleased to be able to obtain a full range of quality advanced woundcare
products for some of our Asian markets.  AMS, with its R & D and manufacturing
capabilities, provides an excellent technology partner for us.'



                                    - ENDS -



For further information, please contact:


Advanced Medical Solutions Group plc         Tel : [phone]
Don Evans, Chief Executive
Mary Tavener, Finance Director
www.admedsol.com


Buchanan Communications                      Tel : [phone]
Mark Court, Mary-Jane Johnson



Notes to Editors:



Advanced Medical Solutions is a leading company in the development and
manufacture of products for the $15 billion global woundcare market.



Founded in 1991 and currently quoted on AIM, Advanced Medical Solutions is
focused on the design, development and manufacture of innovative and
technologically advanced products for woundcare and other medical applications.



In-house natural and synthetic polymer technology is used to provide advanced
wound dressings based on the moist healing principle. AMS's resources ensure a
unique position as a vertically integrated 'one stop shop' to provide all
categories of moist wound healing products. The Company has the capability to
move from product design and development through to production and delivery
ready for distribution into customer markets.



The acquisition of MedLogic in 2002 has brought AMS products and technology in
cyanoacrylate based tissue adhesives and sealants sold direct to hospitals or
through distributors.



AMS's technology and products currently serve the majority of the key global
markets with strategic partners including 3M, Novartis, Johnson & Johnson,
Molnlycke Healthcare, Coloplast, Smith + Nephew and Beiersdorf.






                      This information is provided by RNS
            The company news service from the London Stock Exchange